Cadence Bank NA’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,570
Closed -$201K 217
2022
Q1
$201K Buy
+1,570
New +$189K 0.06% 209
2021
Q4
Sell
-1,617
Closed -$230K 220
2021
Q3
$230K Hold
1,617
0.07% 199
2021
Q2
$252K Hold
1,617
0.08% 188
2021
Q1
$251K Hold
1,617
0.08% 184
2020
Q4
$242K Hold
1,617
0.09% 171
2020
Q3
$214K Buy
+1,617
New +$211K 0.08% 170
2020
Q1
Sell
-1,608
Closed -$234K 181
2019
Q4
$234K Hold
1,608
0.09% 168
2019
Q3
$214K Buy
+1,608
New +$208K 0.08% 170
2018
Q4
Sell
-1,721
Closed -$220K 177
2018
Q3
$220K Buy
+1,721
New +$205K 0.08% 169
2018
Q1
Sell
-1,738
Closed -$204K 180
2017
Q4
$204K Buy
+1,738
New +$197K 0.07% 176
2017
Q3
Sell
-1,738
Closed -$217K 183
2017
Q2
$217K Buy
1,738
+51
+3% +$6.05K 0.1% 129
2017
Q1
$200K Buy
+1,687
New +$191K 0.09% 133
2016
Q4
Sell
-1,607
Closed -$203K 137
2016
Q3
$203K Buy
+1,607
New +$199K 0.09% 127

Other funds holding ZBH

Cadence Bank NA's ZBH Position: Q2 2022 in Review

Cadence Bank NA sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 1,570 shares — an estimated $201K sold.

Cadence Bank NA first reported a position in ZBH in Q3 2016 and held it in 13 quarters. The position peaked at $252K in Q2 2021. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

  • Cadence Bank NA reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
  • Cadence Bank NA sold 1,570 Zimmer Biomet shares in Q2 2022, an estimated $201K.
  • Cadence Bank NA first reported a position in Zimmer Biomet in Q3 2016 and held it in 13 quarters.
  • Cadence Bank NA's Zimmer Biomet position peaked at $252K in Q2 2021.
  • 956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Cadence Bank NA's 13F filing for Q2 2022, filed 20 Jul 2022.